Elucidating the precise pharmacological mechanism of motion (MOA) of naturally occurring compounds is usually complicated. While Tarselli et al. (60) created the primary de novo artificial pathway to conolidine and showcased this naturally happening compound successfully suppresses responses to each chemically induced and inflammation-derived pain,